Chicago IVF

Skokie, Illinois 60077

Medical Director: Joel G. Brasch, MD

Chicago IVF, located in Skokie, Illinois, offers comprehensive fertility care under the guidance of Medical Director Dr. Joel G. Brasch. The clinic provides a full range of reproductive services, including in vitro fertilization (IVF), egg freezing, donor egg programs, and surrogacy support. Their laboratory maintains verified accreditation, ensuring that your treatment takes place in a carefully monitored, high-quality environment.

When it comes to outcomes, Chicago IVF demonstrates solid success rates that reflect their commitment to helping families grow. For patients under 35, their live birth rate is 32.70%, while patients ages 35-37 achieve a 32.10% live birth rate. With 707 treatment cycles performed in 2022, the clinic maintains steady experience treating patients across different fertility challenges. These numbers represent real families who have found their path to parenthood, and while every journey is unique, Chicago IVF's consistent track record offers a foundation of hope and expertise as you consider your own fertility options.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Donor Egg

Uses eggs from a screened donor for patients who cannot use their own.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3532.70%-15.732.30%48.4%
35–3732.10%-3.941.70%36%
38–4021.30%-2.330.60%23.6%
Over 406.30%-3.213.80%9.5%

Based on 707 total cycles reported. National averages computed across all reporting clinics.

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.